P53-HSP70 complexes in oral dysplasia and cancer: Potential prognostic implications

被引:29
作者
Kaur, J
Srivastava, A
Ralhan, R
机构
[1] ALL INDIA INST MED SCI,DEPT BIOCHEM,NEW DELHI 110029,INDIA
[2] ALL INDIA INST MED SCI,DEPT SURG,NEW DELHI 110029,INDIA
来源
ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B | 1996年 / 32B卷 / 01期
关键词
p53; HSP70; p53-HSP70; complex; oral cancer; dysplasia;
D O I
10.1016/0964-1955(95)00054-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have previously shown overexpression of p53 and 70 kDa heat shock protein (HSP70) in potentially malignant, as well as malignant, oral lesions in an Indian population, suggesting that alterations of p53 and HSP70 expression may occur in the early stages of oral tumorigenesis. Herein we report immunological evidence for the specific association between p53 and HSP70 in potentially malignant and malignant oral lesions. This association was indicated by coimmunoprecipitation of p53 and HSP72/73 proteins observed with either an anti-p53 monoclonal antibody or an anti-HSP72/73 antibody. Furthermore, reciprocal blotting analysis showed that HSP72/73 proteins did not share an epitope with p53, confirming that the coimmunoprecipitation of p53 and HSP72/73 is a physical association of the proteins in potentially malignant lesions (dysplasia) and oral squamous cell carcinomas (SCCs). p53-HSP70 complex formation was observed in 19/52 cases of oral SCCs and 10/53 cases of potentially malignant lesions (leucoplakia). Normal oral mucosa did not show the presence of p53-HSP70 complexes (0/20 cases). p53-HSP70 complex formation may be one of the mechanisms of stabilisation of p53 protein resulting in its increased levels in potentially malignant and malignant oral lesions and may be implicated in oral carcinogenesis.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 23 条
[1]   REGULATION OF THE HUMAN HSP70 PROMOTER BY P53 [J].
AGOFF, SN ;
HOU, J ;
LINZER, DIH ;
WU, B .
SCIENCE, 1993, 259 (5091) :84-87
[2]  
BOYLE JO, 1993, CANCER RES, V53, P4477
[3]   MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[4]  
CHUNG KY, 1993, CANCER RES, V53, P1676
[5]  
COLTRERA MD, 1992, AM J PATHOL, V141, P817
[6]  
DAFTARY DK, 1990, RISK MARKERS ORAL DI, V2
[7]   IMMUNE-RESPONSE TO P53 IS DEPENDENT UPON P53/HSP70 COMPLEXES IN BREAST CANCERS [J].
DAVIDOFF, AM ;
IGLEHART, JD ;
MARKS, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3439-3442
[8]   P53 OVER-EXPRESSION IS AN EARLY EVENT IN THE DEVELOPMENT OF HUMAN SQUAMOUS-CELL CARCINOMA OF THE LARYNX - GENETIC AND PROGNOSTIC IMPLICATIONS [J].
DOLCETTI, R ;
DOGLIONI, C ;
MAESTRO, R ;
GASPAROTTO, D ;
BARZAN, L ;
PASTORE, A ;
ROMANELLI, M ;
BOIOCCHI, M .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (02) :178-182
[9]  
EHRHART JC, 1988, ONCOGENE, V3, P595
[10]  
GREENBLATT MS, 1994, CANCER RES, V54, P4855